ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Pittsburgh, PA, USA:

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....

Enrolling
T-cell Lymphoma
Cutaneous T-cell Lymphoma
Drug: Fenretinide

Phase 1

SciTech Development

Pittsburgh, Pennsylvania, United States and 8 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Pittsburgh, Pennsylvania, United States and 71 other locations

combination Golcadomide and nivolumab in patients with non-Hodgkin lymphoma (NHL) who have experienced refractory/residual disease, at or af...

Not yet enrolling
Non Hodgkin Lymphoma
Drug: GOLCADOMIDE
Drug: Nivolumab

Phase 1, Phase 2

Natalie Galanina

Pittsburgh, Pennsylvania, United States

Locations recently updated

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Enrolling
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Pittsburgh, Pennsylvania, United States and 56 other locations

2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in participants with R/R primary central nervous system lymphoma...

Enrolling
Refractory Primary Central Nervous System Lymphoma
Relapsed Primary Central Nervous System Lymphoma
Drug: Emavusertib
Drug: Ibrutinib

Phase 1, Phase 2

Curis

Pittsburgh, Pennsylvania, United States and 42 other locations

pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...

Enrolling
Other CD8+/NK Cell Driven Lymphoma Not Listed Above
Subcutaneous Panniculitis-Like T-Cell Lymphoma
Drug: DR-01

Phase 1, Phase 2

Dren Bio

Pittsburgh, Pennsylvania, United States and 33 other locations

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Active, not recruiting
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Phase 3

Loxo Oncology
Loxo Oncology

Pittsburgh, Pennsylvania, United States and 226 other locations

The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...

Active, not recruiting
Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma (MZL)
Biological: Epcoritamab

Phase 1, Phase 2

Genmab
Genmab

Pittsburgh, Pennsylvania, United States and 84 other locations

1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for whic...

Enrolling
Solid Tumor, Adult Lymphoma
Drug: CYC140

Phase 1, Phase 2

Cyclacel Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 4 other locations

inhibitor for the treatment of relapsed/refractory (R/R) T-cell lymphoma.. This trial will study the safety, tolerability, and anti-tumor ac...

Active, not recruiting
T-cell Lymphoma
Drug: CPI-818

Phase 1

Corvus Pharmaceuticals
Corvus Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems